Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

(2011) Soley Bayraktar et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers

(2011) Larissa J. Lee et al.   CANCER

Response to Neoadjuvant Systemic Therapy for Breast Cancer inBRCAMutation Carriers and Noncarriers: A Single-Institution Experience

(2011) Banu Arun et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Study of Breast Cancer Incidence in Women With aBRCA1orBRCA2Mutation Under Surveillance With and Without Magnetic Resonance Imaging

(2011) Ellen Warner et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study

(2011) Pamela J. Goodwin et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

(2009) Tomasz Byrski et al.   JOURNAL OF CLINICAL ONCOLOGY

Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer

(2009) Ankit Bharat et al.   JOURNAL OF SURGICAL ONCOLOGY